151 Patient outcomes following Lung SABR: The University Hospitals Dorset Experience

University Hospitals Dorset (UHD) began delivering stereotactic ablative body radiotherapy (SABR) for primary and oligometastatic lung cancer in May 2021. Referral criteria were as per the National SABR consortium guidelines. This retrospective study was performed to assess patient outcomes following lung SABR including toxicities, rates of progression/ recurrence and survival.

Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Emma Mackenzie, Jonathan Ah-Chuen, Mike Bayne, Mark Noble, Deborah Scott Tags: Radiotherapy Source Type: research